Linezolid: idoneidad de prescripción y afectación de la función renal y hematológica Linezolid: suitability of prescription and its effects on renal function and haematology

The objective of the study was to evaluate the suitability of linezolid prescription, incidence of thrombocytopenia in critically ill patients and its infl uence on critical ill patients with renal disorder before the linezolid treatment. We observed that the 37.5% of linezolid prescriptions were in Non-Approved Indications in Spain (NAIS). The incidence of thrombocytopenia was 5.9%. We observed a signifi cant improvement in renal function of patients after two weeks of linezolid treatment (p=0.024). The incidence of thrombocytopenia was similar to describe in bibliography. It seems to be necessary approved news indications in Spain.